Cargando…

Corrigendum: Impact of Non-Persistence on Healthcare Resource Utilization Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study

Detalles Bibliográficos
Autores principales: Carballo, Nuria, Garcia-Alzórriz, Enric, Ferrández, Olivia, Navarrete-Rouco, María Eugenia, Durán-Jordà, Xavier, Pérez-García, Carolina, Monfort, Jordi, Cots, Francesc, Grau, Santiago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942768/
https://www.ncbi.nlm.nih.gov/pubmed/35341215
http://dx.doi.org/10.3389/fphar.2022.867017
_version_ 1784673376421281792
author Carballo, Nuria
Garcia-Alzórriz, Enric
Ferrández, Olivia
Navarrete-Rouco, María Eugenia
Durán-Jordà, Xavier
Pérez-García, Carolina
Monfort, Jordi
Cots, Francesc
Grau, Santiago
author_facet Carballo, Nuria
Garcia-Alzórriz, Enric
Ferrández, Olivia
Navarrete-Rouco, María Eugenia
Durán-Jordà, Xavier
Pérez-García, Carolina
Monfort, Jordi
Cots, Francesc
Grau, Santiago
author_sort Carballo, Nuria
collection PubMed
description
format Online
Article
Text
id pubmed-8942768
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89427682022-03-25 Corrigendum: Impact of Non-Persistence on Healthcare Resource Utilization Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study Carballo, Nuria Garcia-Alzórriz, Enric Ferrández, Olivia Navarrete-Rouco, María Eugenia Durán-Jordà, Xavier Pérez-García, Carolina Monfort, Jordi Cots, Francesc Grau, Santiago Front Pharmacol Pharmacology Frontiers Media S.A. 2022-03-07 /pmc/articles/PMC8942768/ /pubmed/35341215 http://dx.doi.org/10.3389/fphar.2022.867017 Text en Copyright © 2022 Carballo, Garcia-Alzórriz, Ferrández, Navarrete-Rouco, Durán-Jordà, Pérez-García, Monfort, Cots and Grau. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Carballo, Nuria
Garcia-Alzórriz, Enric
Ferrández, Olivia
Navarrete-Rouco, María Eugenia
Durán-Jordà, Xavier
Pérez-García, Carolina
Monfort, Jordi
Cots, Francesc
Grau, Santiago
Corrigendum: Impact of Non-Persistence on Healthcare Resource Utilization Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study
title Corrigendum: Impact of Non-Persistence on Healthcare Resource Utilization Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study
title_full Corrigendum: Impact of Non-Persistence on Healthcare Resource Utilization Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study
title_fullStr Corrigendum: Impact of Non-Persistence on Healthcare Resource Utilization Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study
title_full_unstemmed Corrigendum: Impact of Non-Persistence on Healthcare Resource Utilization Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study
title_short Corrigendum: Impact of Non-Persistence on Healthcare Resource Utilization Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study
title_sort corrigendum: impact of non-persistence on healthcare resource utilization costs in patients with immune-mediated rheumatic diseases initiating subcutaneous tnf-alpha inhibitors: a before-and-after study
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942768/
https://www.ncbi.nlm.nih.gov/pubmed/35341215
http://dx.doi.org/10.3389/fphar.2022.867017
work_keys_str_mv AT carballonuria corrigendumimpactofnonpersistenceonhealthcareresourceutilizationcostsinpatientswithimmunemediatedrheumaticdiseasesinitiatingsubcutaneoustnfalphainhibitorsabeforeandafterstudy
AT garciaalzorrizenric corrigendumimpactofnonpersistenceonhealthcareresourceutilizationcostsinpatientswithimmunemediatedrheumaticdiseasesinitiatingsubcutaneoustnfalphainhibitorsabeforeandafterstudy
AT ferrandezolivia corrigendumimpactofnonpersistenceonhealthcareresourceutilizationcostsinpatientswithimmunemediatedrheumaticdiseasesinitiatingsubcutaneoustnfalphainhibitorsabeforeandafterstudy
AT navarreteroucomariaeugenia corrigendumimpactofnonpersistenceonhealthcareresourceutilizationcostsinpatientswithimmunemediatedrheumaticdiseasesinitiatingsubcutaneoustnfalphainhibitorsabeforeandafterstudy
AT duranjordaxavier corrigendumimpactofnonpersistenceonhealthcareresourceutilizationcostsinpatientswithimmunemediatedrheumaticdiseasesinitiatingsubcutaneoustnfalphainhibitorsabeforeandafterstudy
AT perezgarciacarolina corrigendumimpactofnonpersistenceonhealthcareresourceutilizationcostsinpatientswithimmunemediatedrheumaticdiseasesinitiatingsubcutaneoustnfalphainhibitorsabeforeandafterstudy
AT monfortjordi corrigendumimpactofnonpersistenceonhealthcareresourceutilizationcostsinpatientswithimmunemediatedrheumaticdiseasesinitiatingsubcutaneoustnfalphainhibitorsabeforeandafterstudy
AT cotsfrancesc corrigendumimpactofnonpersistenceonhealthcareresourceutilizationcostsinpatientswithimmunemediatedrheumaticdiseasesinitiatingsubcutaneoustnfalphainhibitorsabeforeandafterstudy
AT grausantiago corrigendumimpactofnonpersistenceonhealthcareresourceutilizationcostsinpatientswithimmunemediatedrheumaticdiseasesinitiatingsubcutaneoustnfalphainhibitorsabeforeandafterstudy